title: [Prognostic utility of scintigraphy with 99mTc-HMPAO labelled leukocytes in inflammatory bowel disease].
abstract: OBJECTIVE
  The inflammatory bowel disease (EII) has a chronic evolution with a frequent relapses. There is no specific diagnosis method to detect the patients with a high risk to relapse. The aim of the work was to analyse the prognostic value of 99mTc-HMPAO leukocyte scintigraphy (LS) performed during an acute attack of EII.
  
  
  METHODS
  18 patients (mean age 32 +/- 10 years) admitted for an acute attack of EII has been prospectively studied (5 ulcerative colitis [UC] and 13 Cronh's disease [CD]), excluding patient with prior steroids or immunosuppressive therapy during the last year. LS were obtained in basal conditions and following 3 weeks of steroid treatment and the scintigraphic activity index (SAI) has been calculated. Colonoscopy has been done in all patients, and CDAI in CD and Truelove index in UC have been calculated. Patients were followed up for 1 year. In the evolution the therapy requirements as well as the good response to initial treatment have been evaluated.
  
  
  RESULTS
  All patients with UC and 4 patients with CD showed a SAI decrease > 50 % and all had a good clinical evolution. Only 2 out of the 9 patients with CD showing a IAG decrease < 50 % and had a good clinical evolution, the 7 remaining required additional medical treatment (immunosuppressors or surgery).
  
  
  CONCLUSIONS
  LS may be of prognostic value in the management of EII. A SAI decrease > 50 % at 3 weeks of steroid treatment indicates a good clinical evolution.
authors.affiliation: Servicio de Medicina Nuclear, Hospital Universitari de Bellvitge-IDIBELL, Barcelona.
authors.forename: D
authors.initials: D
authors.lastname: Carrera
authors.forename: A
authors.initials: A
authors.lastname: Domenech
authors.forename: J
authors.initials: J
authors.lastname: Mora
authors.forename: R
authors.initials: R
authors.lastname: Ballester
authors.forename: M
authors.initials: M
authors.lastname: Roca
authors.forename: R I
authors.initials: RI
authors.lastname: Jiménez
authors.forename: B
authors.initials: B
authors.lastname: Verdura
authors.forename: C
authors.initials: C
authors.lastname: Baliellas
authors.forename: J
authors.initials: J
authors.lastname: Guardiola
authors.forename: J
authors.initials: J
authors.lastname: Martín-Comín
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000000981:diagnostic imaging*; D007962:Leukocytes; D008297:Male; D011379:Prognosis; D011446:Prospective Studies; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D019690:Technetium Tc 99m Exametazime
chemical_list: D019275:Radiopharmaceuticals; D019690:Technetium Tc 99m Exametazime